Home › Abdominal Aortic Aneurysm › NCT04246463
Terumo Aortic Global Endovascular Registry
RecruitingObservational study
A Global Post Market Evaluation of Terumo Aortic Endovascular Grafts
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Minimum age as per local regulations * Indication for aortic endovascular repair with an approved or CE marked by a Regulatory body or custom-made Terumo Aortic Endovascular graft * Ability to provide informed consent o Emergent cases (typically younger patients with traumatic injuries) are not excluded if there is IRB/EC agreement to allow consent after intervention (i.e. consent to study participation, not to treatment) or use of a Legally Authorized Representative (LAR). * Willingness to comply with the registry protocol * Willingness to adhere to follow-up visits Note: Patients currently enrolled and actively participating within the TREO registry (IP-0020-16) can have their data migrated from TREO to the TiGER registry where local EC approval has been obtained and the patient has been reconsented to TiGER for longer follow-up. Exclusion Criteria: Patient is unable or unwilling to comply with the study follow-up regime. Patient is contraindicated per the IFU, or has any other medical, social or psychological problems that in the opinion of the investigator preclude them from receiving treatment as well as the procedures and evaluations pre and post procedure.
About the study
Multi-arm, multi-center, open label, prospective observational registry designed to obtain safety and performance data on the use of CE marked and custom Terumo Aortic endovascular grafts.
What is being tested
- Thoracic (device)
- Abdominal (device)
- Custom Device (device)
- Illiac Artery (device)
Sponsor: Vascutek Ltd. · Participants: 1,000 · Started: Dec 17, 2019
Contact the study team
- Michelle Durnan · Phone: +44 141 343 0195
- Sammy Jassal · Phone: +44 141 343 0195
Official record on ClinicalTrials.gov — NCT04246463
Locations in the U.S.
Conditions
From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.